[
    {
        "molecule_name": "monoclonal antibody or an antigen-binding fragment thereof",
        "protein_target_name": "BCMA",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤100",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some aspects, the monoclonal antibody or an antigen-binding fragment thereof may bind to BCMA with a KD less than or equal to 100 nanomolar (e.g., 100 nM, about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, about 20 nM, or about 10 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 10 nanomolar (e.g., about 9 nM, about 8.5 nM, about 8 nM, about 7.5 nM, about 7 nM, about 6.5 nM, about 6 nM, about 5.5 nM, about 5 nM, about 4.5 nM, about 4 nM, about 3.5 nM, about 3 nM, about 2.5 nM, about 2 nM, about 1.5 nM, about 1 nM, about 0.9 nM, about 0.8 nM, about 0.7 nM, about 0.6 nM, about 0.5 nM, about 0.4 nM, about 0.3 nM, about 0.2 nM, about 0.1 nM, about 0.05 nM, about 0.025 nM, about 0.01 nM, about 0.001 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 200 pM (e.g., about 190 pM, about 175 pM, about 150 pM, about 125 pM, about 110 pM, about 100 pM, about 90 pM, about 80 pM, about 75 pM, about 60 pM, about 50 pM, about 40 pM, about 30 pM, about 25 pM, about 20 pM, about 15 pM, about 10 pM, about 5 pM, about 1 pM, or a range defined by any two of the foregoing values).\nIn some aspects, the affinity of the anti-BCMA antibody or antigen-binding fragment thereof to monomeric (soluble) BCMA, as measured by surface plasmon resonance (SPR), is about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, or a range defined by any two of the foregoing values, for example, about 50 nM to about 70 nM, about 55 nM to about 65 nM, or about 58 nM to about 62 nM.\nIn some aspects, the ADC comprises an anti-BCMA antibody or antigen-biding fragment thereof that binds to monomeric (soluble) BCMA with a binding affinity of about 60 nM, as measured by SPR.\nIn some aspects, the anti-BCMA antibody or antigen-biding fragment thereof binds to monomeric (soluble) BCMA with a binding affinity of 60.7 nM, as measured by SPR."
    },
    {
        "molecule_name": "monoclonal antibody",
        "protein_target_name": "BCMA",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤10",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some aspects, the monoclonal antibody or an antigen-binding fragment thereof may bind to BCMA with a KD less than or equal to 100 nanomolar (e.g., 100 nM, about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, about 20 nM, or about 10 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 10 nanomolar (e.g., about 9 nM, about 8.5 nM, about 8 nM, about 7.5 nM, about 7 nM, about 6.5 nM, about 6 nM, about 5.5 nM, about 5 nM, about 4.5 nM, about 4 nM, about 3.5 nM, about 3 nM, about 2.5 nM, about 2 nM, about 1.5 nM, about 1 nM, about 0.9 nM, about 0.8 nM, about 0.7 nM, about 0.6 nM, about 0.5 nM, about 0.4 nM, about 0.3 nM, about 0.2 nM, about 0.1 nM, about 0.05 nM, about 0.025 nM, about 0.01 nM, about 0.001 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 200 pM (e.g., about 190 pM, about 175 pM, about 150 pM, about 125 pM, about 110 pM, about 100 pM, about 90 pM, about 80 pM, about 75 pM, about 60 pM, about 50 pM, about 40 pM, about 30 pM, about 25 pM, about 20 pM, about 15 pM, about 10 pM, about 5 pM, about 1 pM, or a range defined by any two of the foregoing values).\nIn some aspects, the affinity of the anti-BCMA antibody or antigen-binding fragment thereof to monomeric (soluble) BCMA, as measured by surface plasmon resonance (SPR), is about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, or a range defined by any two of the foregoing values, for example, about 50 nM to about 70 nM, about 55 nM to about 65 nM, or about 58 nM to about 62 nM.\nIn some aspects, the ADC comprises an anti-BCMA antibody or antigen-biding fragment thereof that binds to monomeric (soluble) BCMA with a binding affinity of about 60 nM, as measured by SPR.\nIn some aspects, the anti-BCMA antibody or antigen-biding fragment thereof binds to monomeric (soluble) BCMA with a binding affinity of 60.7 nM, as measured by SPR."
    },
    {
        "molecule_name": "monoclonal antibody",
        "protein_target_name": "BCMA",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "KD",
        "value": "≤200",
        "unit": "pM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some aspects, the monoclonal antibody or an antigen-binding fragment thereof may bind to BCMA with a KD less than or equal to 100 nanomolar (e.g., 100 nM, about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, about 20 nM, or about 10 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 10 nanomolar (e.g., about 9 nM, about 8.5 nM, about 8 nM, about 7.5 nM, about 7 nM, about 6.5 nM, about 6 nM, about 5.5 nM, about 5 nM, about 4.5 nM, about 4 nM, about 3.5 nM, about 3 nM, about 2.5 nM, about 2 nM, about 1.5 nM, about 1 nM, about 0.9 nM, about 0.8 nM, about 0.7 nM, about 0.6 nM, about 0.5 nM, about 0.4 nM, about 0.3 nM, about 0.2 nM, about 0.1 nM, about 0.05 nM, about 0.025 nM, about 0.01 nM, about 0.001 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 200 pM (e.g., about 190 pM, about 175 pM, about 150 pM, about 125 pM, about 110 pM, about 100 pM, about 90 pM, about 80 pM, about 75 pM, about 60 pM, about 50 pM, about 40 pM, about 30 pM, about 25 pM, about 20 pM, about 15 pM, about 10 pM, about 5 pM, about 1 pM, or a range defined by any two of the foregoing values).\nIn some aspects, the affinity of the anti-BCMA antibody or antigen-binding fragment thereof to monomeric (soluble) BCMA, as measured by surface plasmon resonance (SPR), is about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, or a range defined by any two of the foregoing values, for example, about 50 nM to about 70 nM, about 55 nM to about 65 nM, or about 58 nM to about 62 nM.\nIn some aspects, the ADC comprises an anti-BCMA antibody or antigen-biding fragment thereof that binds to monomeric (soluble) BCMA with a binding affinity of about 60 nM, as measured by SPR.\nIn some aspects, the anti-BCMA antibody or antigen-biding fragment thereof binds to monomeric (soluble) BCMA with a binding affinity of 60.7 nM, as measured by SPR."
    },
    {
        "molecule_name": "anti-BCMA antibody or antigen-binding fragment thereof",
        "protein_target_name": "monomeric (soluble) BCMA",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "affinity",
        "value": "about 90",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some aspects, the monoclonal antibody or an antigen-binding fragment thereof may bind to BCMA with a KD less than or equal to 100 nanomolar (e.g., 100 nM, about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, about 20 nM, or about 10 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 10 nanomolar (e.g., about 9 nM, about 8.5 nM, about 8 nM, about 7.5 nM, about 7 nM, about 6.5 nM, about 6 nM, about 5.5 nM, about 5 nM, about 4.5 nM, about 4 nM, about 3.5 nM, about 3 nM, about 2.5 nM, about 2 nM, about 1.5 nM, about 1 nM, about 0.9 nM, about 0.8 nM, about 0.7 nM, about 0.6 nM, about 0.5 nM, about 0.4 nM, about 0.3 nM, about 0.2 nM, about 0.1 nM, about 0.05 nM, about 0.025 nM, about 0.01 nM, about 0.001 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 200 pM (e.g., about 190 pM, about 175 pM, about 150 pM, about 125 pM, about 110 pM, about 100 pM, about 90 pM, about 80 pM, about 75 pM, about 60 pM, about 50 pM, about 40 pM, about 30 pM, about 25 pM, about 20 pM, about 15 pM, about 10 pM, about 5 pM, about 1 pM, or a range defined by any two of the foregoing values).\nIn some aspects, the affinity of the anti-BCMA antibody or antigen-binding fragment thereof to monomeric (soluble) BCMA, as measured by surface plasmon resonance (SPR), is about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, or a range defined by any two of the foregoing values, for example, about 50 nM to about 70 nM, about 55 nM to about 65 nM, or about 58 nM to about 62 nM.\nIn some aspects, the ADC comprises an anti-BCMA antibody or antigen-biding fragment thereof that binds to monomeric (soluble) BCMA with a binding affinity of about 60 nM, as measured by SPR.\nIn some aspects, the anti-BCMA antibody or antigen-biding fragment thereof binds to monomeric (soluble) BCMA with a binding affinity of 60.7 nM, as measured by SPR."
    },
    {
        "molecule_name": "anti-BCMA antibody or antigen-binding fragment thereof",
        "protein_target_name": "monomeric (soluble) BCMA",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "affinity",
        "value": "about 80",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some aspects, the monoclonal antibody or an antigen-binding fragment thereof may bind to BCMA with a KD less than or equal to 100 nanomolar (e.g., 100 nM, about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, about 20 nM, or about 10 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 10 nanomolar (e.g., about 9 nM, about 8.5 nM, about 8 nM, about 7.5 nM, about 7 nM, about 6.5 nM, about 6 nM, about 5.5 nM, about 5 nM, about 4.5 nM, about 4 nM, about 3.5 nM, about 3 nM, about 2.5 nM, about 2 nM, about 1.5 nM, about 1 nM, about 0.9 nM, about 0.8 nM, about 0.7 nM, about 0.6 nM, about 0.5 nM, about 0.4 nM, about 0.3 nM, about 0.2 nM, about 0.1 nM, about 0.05 nM, about 0.025 nM, about 0.01 nM, about 0.001 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 200 pM (e.g., about 190 pM, about 175 pM, about 150 pM, about 125 pM, about 110 pM, about 100 pM, about 90 pM, about 80 pM, about 75 pM, about 60 pM, about 50 pM, about 40 pM, about 30 pM, about 25 pM, about 20 pM, about 15 pM, about 10 pM, about 5 pM, about 1 pM, or a range defined by any two of the foregoing values).\nIn some aspects, the affinity of the anti-BCMA antibody or antigen-binding fragment thereof to monomeric (soluble) BCMA, as measured by surface plasmon resonance (SPR), is about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, or a range defined by any two of the foregoing values, for example, about 50 nM to about 70 nM, about 55 nM to about 65 nM, or about 58 nM to about 62 nM.\nIn some aspects, the ADC comprises an anti-BCMA antibody or antigen-biding fragment thereof that binds to monomeric (soluble) BCMA with a binding affinity of about 60 nM, as measured by SPR.\nIn some aspects, the anti-BCMA antibody or antigen-biding fragment thereof binds to monomeric (soluble) BCMA with a binding affinity of 60.7 nM, as measured by SPR."
    },
    {
        "molecule_name": "anti-BCMA antibody or antigen-binding fragment thereof",
        "protein_target_name": "monomeric (soluble) BCMA",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "affinity",
        "value": "about 70",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some aspects, the monoclonal antibody or an antigen-binding fragment thereof may bind to BCMA with a KD less than or equal to 100 nanomolar (e.g., 100 nM, about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, about 20 nM, or about 10 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 10 nanomolar (e.g., about 9 nM, about 8.5 nM, about 8 nM, about 7.5 nM, about 7 nM, about 6.5 nM, about 6 nM, about 5.5 nM, about 5 nM, about 4.5 nM, about 4 nM, about 3.5 nM, about 3 nM, about 2.5 nM, about 2 nM, about 1.5 nM, about 1 nM, about 0.9 nM, about 0.8 nM, about 0.7 nM, about 0.6 nM, about 0.5 nM, about 0.4 nM, about 0.3 nM, about 0.2 nM, about 0.1 nM, about 0.05 nM, about 0.025 nM, about 0.01 nM, about 0.001 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 200 pM (e.g., about 190 pM, about 175 pM, about 150 pM, about 125 pM, about 110 pM, about 100 pM, about 90 pM, about 80 pM, about 75 pM, about 60 pM, about 50 pM, about 40 pM, about 30 pM, about 25 pM, about 20 pM, about 15 pM, about 10 pM, about 5 pM, about 1 pM, or a range defined by any two of the foregoing values).\nIn some aspects, the affinity of the anti-BCMA antibody or antigen-binding fragment thereof to monomeric (soluble) BCMA, as measured by surface plasmon resonance (SPR), is about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, or a range defined by any two of the foregoing values, for example, about 50 nM to about 70 nM, about 55 nM to about 65 nM, or about 58 nM to about 62 nM.\nIn some aspects, the ADC comprises an anti-BCMA antibody or antigen-biding fragment thereof that binds to monomeric (soluble) BCMA with a binding affinity of about 60 nM, as measured by SPR.\nIn some aspects, the anti-BCMA antibody or antigen-biding fragment thereof binds to monomeric (soluble) BCMA with a binding affinity of 60.7 nM, as measured by SPR."
    },
    {
        "molecule_name": "anti-BCMA antibody or antigen-binding fragment thereof",
        "protein_target_name": "monomeric (soluble) BCMA",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "affinity",
        "value": "about 60",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some aspects, the monoclonal antibody or an antigen-binding fragment thereof may bind to BCMA with a KD less than or equal to 100 nanomolar (e.g., 100 nM, about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, about 20 nM, or about 10 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 10 nanomolar (e.g., about 9 nM, about 8.5 nM, about 8 nM, about 7.5 nM, about 7 nM, about 6.5 nM, about 6 nM, about 5.5 nM, about 5 nM, about 4.5 nM, about 4 nM, about 3.5 nM, about 3 nM, about 2.5 nM, about 2 nM, about 1.5 nM, about 1 nM, about 0.9 nM, about 0.8 nM, about 0.7 nM, about 0.6 nM, about 0.5 nM, about 0.4 nM, about 0.3 nM, about 0.2 nM, about 0.1 nM, about 0.05 nM, about 0.025 nM, about 0.01 nM, about 0.001 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 200 pM (e.g., about 190 pM, about 175 pM, about 150 pM, about 125 pM, about 110 pM, about 100 pM, about 90 pM, about 80 pM, about 75 pM, about 60 pM, about 50 pM, about 40 pM, about 30 pM, about 25 pM, about 20 pM, about 15 pM, about 10 pM, about 5 pM, about 1 pM, or a range defined by any two of the foregoing values).\nIn some aspects, the affinity of the anti-BCMA antibody or antigen-binding fragment thereof to monomeric (soluble) BCMA, as measured by surface plasmon resonance (SPR), is about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, or a range defined by any two of the foregoing values, for example, about 50 nM to about 70 nM, about 55 nM to about 65 nM, or about 58 nM to about 62 nM.\nIn some aspects, the ADC comprises an anti-BCMA antibody or antigen-biding fragment thereof that binds to monomeric (soluble) BCMA with a binding affinity of about 60 nM, as measured by SPR.\nIn some aspects, the anti-BCMA antibody or antigen-biding fragment thereof binds to monomeric (soluble) BCMA with a binding affinity of 60.7 nM, as measured by SPR."
    },
    {
        "molecule_name": "anti-BCMA antibody or antigen-binding fragment thereof",
        "protein_target_name": "monomeric (soluble) BCMA",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "affinity",
        "value": "about 50",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some aspects, the monoclonal antibody or an antigen-binding fragment thereof may bind to BCMA with a KD less than or equal to 100 nanomolar (e.g., 100 nM, about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, about 20 nM, or about 10 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 10 nanomolar (e.g., about 9 nM, about 8.5 nM, about 8 nM, about 7.5 nM, about 7 nM, about 6.5 nM, about 6 nM, about 5.5 nM, about 5 nM, about 4.5 nM, about 4 nM, about 3.5 nM, about 3 nM, about 2.5 nM, about 2 nM, about 1.5 nM, about 1 nM, about 0.9 nM, about 0.8 nM, about 0.7 nM, about 0.6 nM, about 0.5 nM, about 0.4 nM, about 0.3 nM, about 0.2 nM, about 0.1 nM, about 0.05 nM, about 0.025 nM, about 0.01 nM, about 0.001 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 200 pM (e.g., about 190 pM, about 175 pM, about 150 pM, about 125 pM, about 110 pM, about 100 pM, about 90 pM, about 80 pM, about 75 pM, about 60 pM, about 50 pM, about 40 pM, about 30 pM, about 25 pM, about 20 pM, about 15 pM, about 10 pM, about 5 pM, about 1 pM, or a range defined by any two of the foregoing values).\nIn some aspects, the affinity of the anti-BCMA antibody or antigen-binding fragment thereof to monomeric (soluble) BCMA, as measured by surface plasmon resonance (SPR), is about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, or a range defined by any two of the foregoing values, for example, about 50 nM to about 70 nM, about 55 nM to about 65 nM, or about 58 nM to about 62 nM.\nIn some aspects, the ADC comprises an anti-BCMA antibody or antigen-biding fragment thereof that binds to monomeric (soluble) BCMA with a binding affinity of about 60 nM, as measured by SPR.\nIn some aspects, the anti-BCMA antibody or antigen-biding fragment thereof binds to monomeric (soluble) BCMA with a binding affinity of 60.7 nM, as measured by SPR."
    },
    {
        "molecule_name": "anti-BCMA antibody or antigen-binding fragment thereof",
        "protein_target_name": "monomeric (soluble) BCMA",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "affinity",
        "value": "about 40",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some aspects, the monoclonal antibody or an antigen-binding fragment thereof may bind to BCMA with a KD less than or equal to 100 nanomolar (e.g., 100 nM, about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, about 20 nM, or about 10 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 10 nanomolar (e.g., about 9 nM, about 8.5 nM, about 8 nM, about 7.5 nM, about 7 nM, about 6.5 nM, about 6 nM, about 5.5 nM, about 5 nM, about 4.5 nM, about 4 nM, about 3.5 nM, about 3 nM, about 2.5 nM, about 2 nM, about 1.5 nM, about 1 nM, about 0.9 nM, about 0.8 nM, about 0.7 nM, about 0.6 nM, about 0.5 nM, about 0.4 nM, about 0.3 nM, about 0.2 nM, about 0.1 nM, about 0.05 nM, about 0.025 nM, about 0.01 nM, about 0.001 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 200 pM (e.g., about 190 pM, about 175 pM, about 150 pM, about 125 pM, about 110 pM, about 100 pM, about 90 pM, about 80 pM, about 75 pM, about 60 pM, about 50 pM, about 40 pM, about 30 pM, about 25 pM, about 20 pM, about 15 pM, about 10 pM, about 5 pM, about 1 pM, or a range defined by any two of the foregoing values).\nIn some aspects, the affinity of the anti-BCMA antibody or antigen-binding fragment thereof to monomeric (soluble) BCMA, as measured by surface plasmon resonance (SPR), is about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, or a range defined by any two of the foregoing values, for example, about 50 nM to about 70 nM, about 55 nM to about 65 nM, or about 58 nM to about 62 nM.\nIn some aspects, the ADC comprises an anti-BCMA antibody or antigen-biding fragment thereof that binds to monomeric (soluble) BCMA with a binding affinity of about 60 nM, as measured by SPR.\nIn some aspects, the anti-BCMA antibody or antigen-biding fragment thereof binds to monomeric (soluble) BCMA with a binding affinity of 60.7 nM, as measured by SPR."
    },
    {
        "molecule_name": "anti-BCMA antibody or antigen-binding fragment thereof",
        "protein_target_name": "monomeric (soluble) BCMA",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "affinity",
        "value": "about 30",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some aspects, the monoclonal antibody or an antigen-binding fragment thereof may bind to BCMA with a KD less than or equal to 100 nanomolar (e.g., 100 nM, about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, about 20 nM, or about 10 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 10 nanomolar (e.g., about 9 nM, about 8.5 nM, about 8 nM, about 7.5 nM, about 7 nM, about 6.5 nM, about 6 nM, about 5.5 nM, about 5 nM, about 4.5 nM, about 4 nM, about 3.5 nM, about 3 nM, about 2.5 nM, about 2 nM, about 1.5 nM, about 1 nM, about 0.9 nM, about 0.8 nM, about 0.7 nM, about 0.6 nM, about 0.5 nM, about 0.4 nM, about 0.3 nM, about 0.2 nM, about 0.1 nM, about 0.05 nM, about 0.025 nM, about 0.01 nM, about 0.001 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 200 pM (e.g., about 190 pM, about 175 pM, about 150 pM, about 125 pM, about 110 pM, about 100 pM, about 90 pM, about 80 pM, about 75 pM, about 60 pM, about 50 pM, about 40 pM, about 30 pM, about 25 pM, about 20 pM, about 15 pM, about 10 pM, about 5 pM, about 1 pM, or a range defined by any two of the foregoing values).\nIn some aspects, the affinity of the anti-BCMA antibody or antigen-binding fragment thereof to monomeric (soluble) BCMA, as measured by surface plasmon resonance (SPR), is about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, or a range defined by any two of the foregoing values, for example, about 50 nM to about 70 nM, about 55 nM to about 65 nM, or about 58 nM to about 62 nM.\nIn some aspects, the ADC comprises an anti-BCMA antibody or antigen-biding fragment thereof that binds to monomeric (soluble) BCMA with a binding affinity of about 60 nM, as measured by SPR.\nIn some aspects, the anti-BCMA antibody or antigen-biding fragment thereof binds to monomeric (soluble) BCMA with a binding affinity of 60.7 nM, as measured by SPR."
    },
    {
        "molecule_name": "ADC",
        "protein_target_name": "monomeric (soluble) BCMA",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "binding affinity",
        "value": "about 60",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some aspects, the monoclonal antibody or an antigen-binding fragment thereof may bind to BCMA with a KD less than or equal to 100 nanomolar (e.g., 100 nM, about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, about 20 nM, or about 10 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 10 nanomolar (e.g., about 9 nM, about 8.5 nM, about 8 nM, about 7.5 nM, about 7 nM, about 6.5 nM, about 6 nM, about 5.5 nM, about 5 nM, about 4.5 nM, about 4 nM, about 3.5 nM, about 3 nM, about 2.5 nM, about 2 nM, about 1.5 nM, about 1 nM, about 0.9 nM, about 0.8 nM, about 0.7 nM, about 0.6 nM, about 0.5 nM, about 0.4 nM, about 0.3 nM, about 0.2 nM, about 0.1 nM, about 0.05 nM, about 0.025 nM, about 0.01 nM, about 0.001 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 200 pM (e.g., about 190 pM, about 175 pM, about 150 pM, about 125 pM, about 110 pM, about 100 pM, about 90 pM, about 80 pM, about 75 pM, about 60 pM, about 50 pM, about 40 pM, about 30 pM, about 25 pM, about 20 pM, about 15 pM, about 10 pM, about 5 pM, about 1 pM, or a range defined by any two of the foregoing values).\nIn some aspects, the affinity of the anti-BCMA antibody or antigen-binding fragment thereof to monomeric (soluble) BCMA, as measured by surface plasmon resonance (SPR), is about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, or a range defined by any two of the foregoing values, for example, about 50 nM to about 70 nM, about 55 nM to about 65 nM, or about 58 nM to about 62 nM.\nIn some aspects, the ADC comprises an anti-BCMA antibody or antigen-biding fragment thereof that binds to monomeric (soluble) BCMA with a binding affinity of about 60 nM, as measured by SPR.\nIn some aspects, the anti-BCMA antibody or antigen-biding fragment thereof binds to monomeric (soluble) BCMA with a binding affinity of 60.7 nM, as measured by SPR."
    },
    {
        "molecule_name": "anti-BCMA antibody or antigen-biding fragment thereof",
        "protein_target_name": "monomeric (soluble) BCMA",
        "protein_uniprot_id": null,
        "protein_seq_id": null,
        "binding_metric": "binding affinity",
        "value": "60.7",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nIn some aspects, the monoclonal antibody or an antigen-binding fragment thereof may bind to BCMA with a KD less than or equal to 100 nanomolar (e.g., 100 nM, about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, about 20 nM, or about 10 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 10 nanomolar (e.g., about 9 nM, about 8.5 nM, about 8 nM, about 7.5 nM, about 7 nM, about 6.5 nM, about 6 nM, about 5.5 nM, about 5 nM, about 4.5 nM, about 4 nM, about 3.5 nM, about 3 nM, about 2.5 nM, about 2 nM, about 1.5 nM, about 1 nM, about 0.9 nM, about 0.8 nM, about 0.7 nM, about 0.6 nM, about 0.5 nM, about 0.4 nM, about 0.3 nM, about 0.2 nM, about 0.1 nM, about 0.05 nM, about 0.025 nM, about 0.01 nM, about 0.001 nM, or a range defined by any two of the foregoing values).\nIn another embodiment, the monoclonal antibody may bind to BCMA with a KD less than or equal to 200 pM (e.g., about 190 pM, about 175 pM, about 150 pM, about 125 pM, about 110 pM, about 100 pM, about 90 pM, about 80 pM, about 75 pM, about 60 pM, about 50 pM, about 40 pM, about 30 pM, about 25 pM, about 20 pM, about 15 pM, about 10 pM, about 5 pM, about 1 pM, or a range defined by any two of the foregoing values).\nIn some aspects, the affinity of the anti-BCMA antibody or antigen-binding fragment thereof to monomeric (soluble) BCMA, as measured by surface plasmon resonance (SPR), is about 90 nM, about 80 nM, about 70 nM, about 60 nM, about 50 nM, about 40 nM, about 30 nM, or a range defined by any two of the foregoing values, for example, about 50 nM to about 70 nM, about 55 nM to about 65 nM, or about 58 nM to about 62 nM.\nIn some aspects, the ADC comprises an anti-BCMA antibody or antigen-biding fragment thereof that binds to monomeric (soluble) BCMA with a binding affinity of about 60 nM, as measured by SPR.\nIn some aspects, the anti-BCMA antibody or antigen-biding fragment thereof binds to monomeric (soluble) BCMA with a binding affinity of 60.7 nM, as measured by SPR."
    }
]